We are live on
!
Find out more
Aberdeen Group Portfolio holdings
AUM
$71.2B
Turnover
9.3%
1-Year Est. Return
41.74%
This Fund
S&P 500
This Quarter
Est. Return
+0.97%
1 Year Est. Return
+41.74%
3 Year Est. Return
+120.47%
5 Year Est. Return
+149.18%
10 Year Est. Return
–
AUM
$40.1B
AUM Growth
-$4.93B
(-11%)
Cap. Flow
-$4.88B
Cap. Flow
% of AUM
-12.17%
Top 10 Holdings %
Top 10 Hldgs %
19.14%
Holding
959
New
32
Increased
238
Reduced
614
Closed
39
Avg Time Held
1.7
years
Top 10 Avg Time Held
1.3
years
Top 20 Avg Time Held
1.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Information Services
FIS
|
+$192M |
| 2 |
Fiserv Inc
FISV
|
+$93.4M |
| 3 |
American Express
AXP
|
+$91.1M |
| 4 |
Prologis
PLD
|
+$86.5M |
| 5 |
AbbVie
ABBV
|
+$84M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$206M |
| 2 |
Microsoft
MSFT
|
+$197M |
| 3 |
Apple
AAPL
|
+$164M |
| 4 |
RTN
Raytheon Company
RTN
|
+$154M |
| 5 |
Chevron
CVX
|
+$119M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.19% |
| 2 | Financials | 15.72% |
| 3 | Consumer Discretionary | 12.22% |
| 4 | Healthcare | 10.98% |
| 5 | Communication Services | 10.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
776
Nektar Therapeutics
NKTR
$1.29B
| $1.21M | ﹤0.01% |
4,429
-5,596
| -56% | -$2.05M |
2017 Q3
8 quarters
|
|
777
AutoNation
AN
$5.28B
| $1.2M | ﹤0.01% |
23,736
-976
| -4% | -$46K |
2017 Q3
8 quarters
|
|
778
Dycom Industries
DY
$7.77B
| $1.17M | ﹤0.01% |
23,000
| – | – |
2018 Q2
5 quarters
|
|
779
Elanco Animal Health
ELAN
$11.8B
| $1.17M | ﹤0.01% |
44,018
+2,346
| +6% | +$70.4K |
2019 Q1
2 quarters
|
|
780
Goodyear
GT
$1.27B
| $1.16M | ﹤0.01% |
80,676
-19,807
| -20% | -$264K |
2017 Q3
8 quarters
|
|
781
Canadian Pacific Kansas City
CP
$76.4B
| $1.16M | ﹤0.01% |
26,000
-308,000
| -92% | -$14.5M |
2018 Q2
5 quarters
|
|
782
AXIS Capital
AXS
$7.15B
| $1.16M | ﹤0.01% |
17,328
-1,051
| -6% | -$66.4K |
2017 Q3
8 quarters
|
|
783
Avis
CAR
$3.88B
| $1.16M | ﹤0.01% |
40,893
-1,681
| -4% | -$51.5K |
2017 Q3
8 quarters
|
|
784
BlackRock TCP Capital
TCPC
$354M
| $1.15M | ﹤0.01% |
85,000
+7,500
| +10% | +$103K |
2018 Q4
3 quarters
|
|
785
Tenet Healthcare
THC
$22.2B
| $1.15M | ﹤0.01% |
52,080
+2,378
| +5% | +$50.7K |
2017 Q3
8 quarters
|
|
786
Littelfuse
LFUS
$9.95B
| $1.14M | ﹤0.01% |
6,400
| – | – |
2017 Q3
8 quarters
|
|
787
SolarEdge
SEDG
$1.93B
| $1.11M | ﹤0.01% |
+13,242
| New | +$987K |
2019 Q3
0 quarters
|
|
788
Tower Semiconductor
TSEM
$23.7B
| $1.1M | ﹤0.01% |
+57,379
| New | +$1.07M |
2019 Q3
0 quarters
|
|
789
Reliance Steel & Aluminium
RS
$20.8B
| $1.08M | ﹤0.01% |
10,892
-448
| -4% | -$43.8K |
2017 Q3
8 quarters
|
|
790
Genworth Financial
GNW
$3.38B
| $1.08M | ﹤0.01% |
246,460
-9,406
| -4% | -$39.2K |
2018 Q3
4 quarters
|
|
791
Sensata Technologies
ST
$6.01B
| $1.08M | ﹤0.01% |
21,641
-3,186
| -13% | -$151K |
2019 Q1
2 quarters
|
|
792
Terreno Realty
TRNO
$6.97B
| $1.08M | ﹤0.01% |
21,217
+576
| +3% | +$28.8K |
2018 Q2
5 quarters
|
|
793
Alnylam Pharmaceuticals
ALNY
$31.3B
| $1.08M | ﹤0.01% |
13,395
+533
| +4% | +$42.2K |
2018 Q2
5 quarters
|
|
794
Ares Capital
ARCC
$13.6B
| $1.08M | ﹤0.01% |
57,800
-89,817
| -61% | -$1.67M |
2018 Q2
5 quarters
|
|
795
Flagstar Bank National Association
FLG
$4.67B
| $1.06M | ﹤0.01% |
28,059
-12,463
| -31% | -$430K |
2017 Q3
8 quarters
|
|
796
TAL Education Group
TAL
$6.96B
| $1.05M | ﹤0.01% |
30,555
-133,144
| -81% | -$4.64M |
2017 Q3
8 quarters
|
|
797
Spotify
SPOT
$110B
| $1.04M | ﹤0.01% |
9,093
+600
| +7% | +$84.7K |
2019 Q2
1 quarter
|
|
798
Golub Capital BDC
GBDC
$3.19B
| $1.04M | ﹤0.01% |
+56,155
| New | +$1.01M |
2019 Q3
0 quarters
|
|
799
DELISTED
Spirit AeroSystems
SPR
| $1.03M | ﹤0.01% |
12,522
-50,311
| -80% | -$3.94M |
2018 Q2
5 quarters
|
|
800
Acuity Brands
AYI
$9.04B
| $1.03M | ﹤0.01% |
7,609
-34,243
| -82% | -$4.46M |
2017 Q3
8 quarters
|
|
Similar funds
Aberdeen Group's Q3 2019 Portfolio in Review
As of Q3 2019, Aberdeen Group held 959 positions worth $40.1B, down 11% from $45B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Aberdeen Group withdrew a net $4.88B in Q3 2019, closing 39 positions and reducing 614 holdings. Its most notable exit was L3Harris, an estimated $88.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Aberdeen Group opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $40.7M.
- Aberdeen Group's largest Q3 2019 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 1,493,397 shares worth $40.7M.
- Aberdeen Group added most to Fidelity National Information Services in Q3 2019, an estimated $192M increase.
- Aberdeen Group's biggest Q3 2019 reduction was Wells Fargo, cutting an estimated $206M.
- Aberdeen Group fully exited L3Harris in Q3 2019, selling an estimated $88.4M.
- Aberdeen Group's ten largest holdings make up 19% of its $40.1B portfolio in Q3 2019.
- Aberdeen Group opened 32 new positions and closed 39 in Q3 2019.
- Aberdeen Group's portfolio value fell 11% quarter-over-quarter to $40.1B.
Based on Aberdeen Group's 13F filing for Q3 2019, filed 13 Nov 2019.